semaglutide prediabetes progression to type 2 diabetes trial Efficacy and safety of once-weekly 2·4 mg versus placebo in people with obesity and (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 Semaglutide for Prediabetes: A Guide
Description
And some of the rats did show potentially premalignant changes in their pancreases on these drugs

It does not accept insurance for any of its GLP-1 treatments
But GLP-1s arent right for everyone

Some patients report elevated blood pressure during dose escalation phases, which typically resolves as their bodies stabilize

semaglutide: side effects Liraglutide and semaglutide share many side effects, both rare and serious

Are data practices transparent enough to withstand public and regulatory scrutiny
